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Abstract: 
In the present study, comparative genome analysis between Clostridium perfringens and the human genome was carried out to identify genes that 
are essential for the pathogen’s survival, and non-homologous to the genes of human host, that can be used as potential drug targets. The study 
resulted in the identification of 426 such genes. The number of these potential drug targets thus identified is significantly lower than the genome’s 
protein coding capacity (2558 protein coding genes). The 426 genes of C. perfringens were further analyzed for overall similarities with the 
essential genes of 14 different bacterial species present in Database of Essential Genes (DEG). Our results show that there are only 5 essential genes 
of C. perfringens that exhibit similarity with 12 species of the 14 different bacterial species present in DEG database. Of these, 1 gene was similar in 
12 species and 4 genes were similar in 11 species. Thus, the study opens a new avenue for the development of potential drugs against the highly 
pathogenic bacterium. Further, by selecting these essential genes of C. perfringens, which are common and essential for other pathogenic microbial 
species, a broad spectrum anti-microbial drug can be developed. As a case study, we have built a homology model of one of the potential drug 
targets, ABC transporter-ATP binding protein, which can be employed for in silico docking studies by suitable inhibitors. 
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Background: 
The availability of the complete genome sequence information of the 
human genome and a large number of microbial genomes’ sequences 
has led to the development of new approaches to understand host-
pathogen interaction. Use of bioinformatics approach and comparative 
analysis of the genome of a pathogenic microbe allows one to identify 
essential genes necessary for the survival of that pathogen. The proteins 
encoded by these essential genes, that are not present or are non-
homologous to the host, can be used as  drug targets. Such an approach 
has been effectively used to identify drug targets in other bacterial 
species such as Pseudomonas aeruginosa  [1, 2],  Helicobacter pylori 
[3],  Mycobacterium tuberculosis  [4],  Burkholderia pseudomallei  [5] 
and Aeromonas hydrophila  [6].  Clostridium perfringens is a Gram-
positive, rod shaped, anaerobic bacterium that is able to form spores. It 
is widely distributed in the environment (e.g. in soil and sewage) and is 
frequently found in the gastrointestinal (GI) tract of humans, many 
domestic and feral animals, as well as in soil and freshwater sediments 
[7]. In humans, it can cause gangrene and gastrointestinal disease (e.g. 
food poisoning and necrotic enteritis), whereas in other animals, 
gastrointestinal and enterotoxemic diseases occur more frequently [8]. 
C. perfringens does not invade healthy cells but produces various toxins 
and enzymes that are responsible for associated lesions and symptoms.  
As a species, C. perfringens is one of the most prolific producers of 
toxins [9]. It has  five biotypes (A, B, C, D and E), which are identified 
by the main types of toxins they produce (alpha, beta, iota, epsilon and 
theta), each type of toxin being associated with a specific syndrome.  C. 
perfringens type A is the most common toxin type in the environment, 
and is responsible for gas gangrene, enterocolitis, dysenteria, and 
enterotoxemia. In the present study, comparative genome analysis of C. 
perfringens  type A  with that of the human genome, and use of the 
Database of Essential Genes (DEG) compiled by Zhang et al.,  [10], 
have resulted in the identification of the essential genes of C. 
perfringens, that could be used as potential drug targets. 
 
Methodology: 
Comparative genome analysis: 
The complete genomes of C. perfringens type A, strain SM101 
(Accession No. NC_008262) [11] and its human host have been 
sequenced and were downloaded from the NCBI website [12]. The 
Database of Essential Genes [10] was accessed from its website [13] 
and sequence alignment was performed using BLASTP. In this analysis, 
the assumption described by Dutta et al., [3] was followed, and proteins 
of less then 100 amino acid residues were excluded from the analysis. 
The remaining proteins were subjected to BLASTP on the NCBI server 
against human protein sequences to identify non-homologous sequences 
[14]. A minimum bit score of 100 and an Expectation value (E-value) 
cutoff of 10
-10 
was selected for shortlisting genes. The shortlisted genes 
were subjected to BLASTP against DEG to identify essential genes. 
Further analysis of the essential genes using the Kyoto Encyclopaedia 
of Genes and Genomes (KEGG) pathway database [15], revealed the 
information about different biological process in which potential target 
genes were involved.  
 
Structure modeling and visualization of model: 
BLASTP analysis was used to identify the most suitable template for 
homology modeling of Clostridium perfringens ABC transporter, ATP 
binding protein (CpABC) (Accession No. YP_698054). Subsequent to 
BLASTP analysis, the sequences of the structures of ABC transporters 
available in the PDB were used. The available structure of ABC 
transporter from Methanococcus jannaschii (Mj0796) in the Protein 
Database (PDB entry 1f3o, resolution=2.70, R value=0.204) was used 
as a template. The target and the template sequences were aligned using 
ClustalW. MODELLER [16], an automated comparative protein 
modeling program, was used for homology modeling to generate the 3-
D structure of CpABC. Further, the structural model generated was 
visualized using the Swiss PDB viewer software [17]. 
 
Validation of the generated model: 
Different structure verification servers such as PROCHECK [18], 
WHAT_CHECK [19], VERIFY3D [20] and ProSA [21] were used to 
evaluate the 3D-model. These verification programs validate the 
predicted structure by checking various parameters. While 
PROCHECK, a structure verification program that relies on 
Ramachandran plot [22], determines the quality of the predicted 
structure by assessing various  parameters such as lengths, angles and 
planarity of the peptide bonds, geometry of the hydrogen bonds, and 
side chain conformations of protein structures as a function of atomic 
resolution,  WHAT_CHECK, a subset of protein verification tools from 
the WHATIF [23], program extensively evaluates the stereochemical 
parameters of the residues in the model [24]. The Verify3D determines 
the compatibility of an atomic model (3D) with its own amino acid 
sequence (1D) by assigning a structural class based on its location and 
environment (alpha, beta, loop, polar, nonpolar etc.) and comparing the 
results to valid structures [25].  Bioinformation   open access 
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Figure 1: Percentage distribution of 426 target genes encoding different classes of proteins in Clostridium perfringens. Around 2% gene
encode the proteins of unknown function. 
 
  
Figure 2: Graphical representation of the number of target genes aving similarity with those of bacterial species present in DEG. The number of 
genes of C. perfringens having similar match to different number of bacterial species is shown on top of the respective bars.  
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Figure 3: CLUSTALW Multiple sequence alignment of CpABC with Mj0796. Single fully conserved residues are represented by (*), conservation 
of strong and weak groups is denoted by (:) and (.), respectively. The boxed sequence represents the Walker A motif, whereas the ABC signature 
sequence is marked by bold overline. 
 
Discussion: 
Identification of drug targets in C. perfringens: 
C. perfringens is the most common cause of gas gangrene in humans. 
Clostridial gas gangrene is a highly lethal necrotizing soft tissue 
infection of skeletal muscle caused by toxins secreted by C. 
perfringens. Although penicillin is one of the preferred antibiotics, it is 
only useful if the infection is diagnosed at early stages. There is no 
other specific drug that can be given to a patient infected with C. 
perfringens. Therefore, more research in this field is required to identify 
new drug targets and develop therapeutic agents for controlling C. 
perfringens infections. Since most antibiotics target essential cellular 
processes, essential gene products of microbial cells are promising new 
targets for antibacterial drugs [10]. Targetting an essential gene 
necessary for the bacterial cell survival may provide an effective way to 
control infection.  
 
The circular genome of C. perfringens comprises 2,897,393 nucleotides 
with a total number of 2701 genes. Of the 2558 protein encoding genes, 
only 2300 genes encode proteins of greater than 100 amino acid 
residues. BLAST analysis of these genes against the human genome 
sequence revealed 1991 genes to be non-homologous to humans. 
Further BLASTP analysis of the 2300 protein coding genes with DEG 
resulted in identification of 726 genes, which had a bit score of at least 
100 at an expectation cutoff value of 10
-10, as similar to the  essential 
genes required for the growth and survival of bacteria listed in the DEG.  
Of these, 426 were found to have no human homologue (see Table 1 in 
Supplementary data).  Pathways information for these genes was 
obtained from KEGG database. All these genes are involved in the 
production of proteins that are useful for various important functions in 
C. perfringens. Out of the 426 identified genes, function of 10 genes 
remains unknown, and 17 genes encode conserved hypothetical 
proteins. The percentage distribution of the genes amongst different 
biological process is shown in Figure 1. A large population of these 
genes (~33%) is involved in metabolic pathways. The major share of 
these genes constitute the proteins involved in transport and translation 
(17% and 12%, respectively). Highly conserved genes, in theory, are 
more likely to be physiologically important [26]; however, they need to 
be experimentally validated. Therefore, the analysis of the 426 essential 
genes of C. perfringens for overall similarities with all 14 species 
present in DEG database was carried out. Results of such an analysis 
are shown in Figure 2.  Out of the 426 essential genes, 160 genes have 
similar match to at least 1 species, whereas on the other end of the 
spectrum, only 4 genes have similar match to 11 species and only 1 
gene has an identity score of more than 100 with 12 different microbial 
species listed in the DEG. From this analysis, it is evident that the 
products of 5 genes (1 gene similar in 12 species and 4 genes similar in 
11 species) are essential for most of the bacterial species present in 
DEG. These  species include Acinetobacter baylyi ADP1, Bacillus 
subtilis,  Escherichia coli MG1655,  Francisella novicida U112, 
Haemophilus influenzae, Helicobacter pylori 26695, Helicobacter 
pylori  J99,  Mycobacterium tuberculosis H37Rv, Mycoplasma 
genitalium  G37, Mycoplasma pulmonis UAB CTIP , Salmonella 
typhimurium, Staphylococcus aureus and Streptococcus pneumoniae. 
Therefore, these 5 genes can be used as potential drug targets for more 
than 10 highly pathogenic bacterial species, in addition to C. 
perfringens. These 5 target genes, thus identified, are ABC transporter-
ATP-binding protein, cell division protein FtsZ, RNA polymerase 
sigma factor RpoD, 50S ribosomal protein L13, and 30S ribosomal 
protein S5. A drug designed against these targets can be effectively 
used to treat other bacterial infections as well. Since the number of thus 
identified potential candidate genes is relatively small, these can be 
experimentally validated to develop broad-spectrum antimicrobial 
drugs. Since ABC transporter-ATP-binding protein is one of the 5 
potential drug targets identified, an attempt has been made to predict its 
structure for effective drug design. 
 
ABC transporter - a potential broad spectrum target: 
ABC (ATP-binding cassette) transporters are ubiquitously present ATP-
dependent transmembrane solute pumps and ion channels. These 
superfamilies contain both uptake and efflux transport systems and form 
one of the largest transporters [27]. The ABC transporters couple 
hydrolysis of ATP to the translocation of various substrates across cell 
membranes. Members of this superfamily recognize substrates ranging 
from single ions to entire protein toxins. ABC transporters have a 
number of highly conserved ABC cassette motifs, many of which are 
involved in the binding and hydrolysis of ATP. It is generally assumed 
that all ABC cassettes bind and hydrolyze ATP in a similar way and use 
a common mechanism to provide energy for substrate transport through 
the membrane-spanning domains [28]. When the substrate has traversed 
the membrane, the transporter returns to the resting state through 
dissociation of ADP and inorganic phosphate. Fluoxetine and 
omeprazole, few of the most widely prescribed drugs in the world, have 
a transporter protein as site of action. Therefore, ABC transporter 
structures have  potential value in drug designing.  
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Figure 4: (A): Homology modeled structure of the C. perfringens ABC transporter, ATP binding protein based on template Mj0796. Model is 
represented in ribbon form as Swiss PDB viewer representation in secondary structure succession color scheme. N and C termini of modeled 
structure are represented as NH3
+ and 
–OOC.  (B) Superimposed image of the modeled structure of CpABC onto Mg-ADP bound Mj0796 (PDB 
entry 1f3o). CpABC is represented in red color, Mg-ADP (shown in green color) bound Mj0796 is represented in blue color. Signature sequence 
LSGG with three conserved residues, Q90, E171, H204 form Mj0796 and Q92, E164, H197 from model CpABC are mentioned.  Arrow indicates 
the deletion of seven amino acids (RKRALEC) in CpABC, which forms an α-helix in the Mj0796. 
 
Structural model and overall architecture of ABC transporter 
(CpABC): 
Sequence alignment of the C. perfringens CpABC and ABC 
transporters from other species revealed Mj0796 to be the best template 
for homology modeling of the target sequence as the CpABC and 
Mj0796 shared 41% identity (Figure 3). Mj0796 is a member of the 
o228/LolD transporter family, involved in the export of lipoproteins via 
the Lol system. LolD contains a characteristic sequence called the LolD 
motif, which is highly conserved among LolD homologs, but not in 
other ABC transporters, and is located between the Walker A 
(GSGKST, boxed) and ABC signature (LSGGQ, marked as bold 
overline) motifs (Figure 3). Comparative sequence analyses, motif 
search, and secondary structure prediction indicated that CpABC is 
structurally similar to the monomer structure of the Mj0796, a lipid 
transporter. The crystal structure of Mj0796 (PDB entry 1f3o) was used 
as a template to predict the structure of CpABC and the predicted 3D 
structure model of CpABC was generated by Modeller, a homology-
modeling program. Figure 4 shows the predicted structure in the form 
of ribbons as a Swiss PDB viewer representation. 
 
Validation of generated model of CpABC: 
The quality of the model was evaluated using the PROCHECK program 
and assessed using the Ramachandran plot. It is evident from the 
Ramchandran plot that the predicted model has 91.4%, 8.1%, and 0.5% 
residues in the most favorable regions, the allowed regions, and the 
disallowed regions, respectively. Such a percentage distribution of the 
protein residues determined by Ramachandran plot shows that the 
predicted model is of  good quality. All Ramachandrans show 6 labelled 
residues out of 220 whereas chi1-chi2 plots show 2 labelled residues out 
of 140. The model shows all the main chain and side chain parameters 
to be in the ‘better’ region. Another factor that is important for the 
predicted model to be reliable is G-factor, which is a log odds score 
based on the observed distribution of stereochemical parameters.  For a 
reliable model, the score for G-factor should be above -0.50. The 
observed G-factor score for the present model was -0.05 for dihedrals 
bonds, -0.31 for covalent bonds, and -0.15 overall. The distribution of 
the main chain bond lengths and bond angles were 98.5% and 93.2% 
within limits, respectively. Also, all the planar groups were within the 
limits. The quality of the generated model of CpABC as evaluated by 
ProSA provided a z-score of -7.2, which falls within the range of values 
observed for the experimentally determined structures of similar 
lengths. The validity of the predicted model of CpABC was also 
verified by employing the structure verification servers 
WHAT_CHECK and Verify-3D.  Superposition of the predicted 
structure of CpABC and the Mg-ADP bound Mj0796 (template, PDB 
entry 1f3o) is shown in Figure 4B.  It is evident from the figure that the 
Mg-ADP binding core of the ABC subunit and all the structural motifs 
are highly conserved in both structures. The two superposed structures 
match 214 Cα atoms with an rms distance of 0.47Å. Three residues 
Q90, E171,   and H204, important for activity of Mj0796, superposed 
very well with conserved residues Q92, E164 and H197 from model 
CpABC. However, a deletion of seven amino acids (RKRALEC), 
which forms an α-helix in the Mj0796 (indicated by arrow), and an 
insertion of three amino acids (PIS) at the C-terminal end of CpABC, is 
observed. Thus, the predicted model structure of C. perfringens ABC 
transporter, ATP binding protein, and CpABC is comparable to the 
structurally resolved Mj0796. 
 
Conclusion: 
Comparative genome analysis is a highly efficient approach for   
idendifing potential proteins that can be used as potential  targets  for 
effective drug designing against pathogenic organisms. It allows 
restricting the potential pool of genes to a much smaller number, 
compared to the whole genome capacity, which can be experimentally 
validated.  In the present study, around 426 drug targets in C. 
perfringens were identified by comparative genome analysis with DEG. Bioinformation   open access 
www.bioinformation.net    Hypothesis
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Further, by using the subtractive genomic approach five essential genes 
were identified that are conserved in more than 10 other pathogenic 
organisms. Since the number of these conserved genes is very small, 
these can be experimentally tested for the development of a broad-
spectrum anti-microbial drug. The drug thus developed is likely to 
inhibit other bacterial infections, which share high sequence similarity 
with the five essential genes of C. perfringens SM101. 
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Supplementary material   
 
Table 1: List of genes that are non-homologs to humans and essential for C. perfringens 
S. No.  Name 
1.  chromosomal replication initiator protein DnaA  
2.  DNA polymerase III, beta subunit  
3.  DNA replication and repair protein RecF  
4.  DNA gyrase, A subunit  
5.  cytidine/deoxycytidylate deaminase  family protein  
6.  MTA/SAH nucleosidase  
7.  HesA/MoeB/ThiF family protein  
8.  glucose-1-phosphate adenylyltransferase  
9.  SACPA operon antiterminator (sacT)  
10.  pts system, glucose-specific iia component  
11.  PTSsystem,N-acetylglucosamine-specific IIBC component  
12.  DNA-binding response regulator  
13.  permease, putative domain protein  
14.  hypothetical protein (CPR_0125) 
15.  NAD-dependent malic enzyme  
16.  carbamate kinase  
17.  N-acetylmannosamine-6-phosphate 2-epimerase, putative  
18.  cobalt ABC transporter, ATP-binding protein  
19.  acetate kinase  
20.  ferrichrome ABC transporter (permease)-like protein lin2287  
21.  ferrichrome ABC transporter  
22.  hypothetical protein (CPR_0223) 
23.  DNA-binding response regulator  
24.  GGDEF/EAL domain-containing protein  
25.  capsular polysaccharide synthesis protein  
26.  teichoic acid translocation permease protein  
27.  teichoic acid ABC transporter, ATP-binding protein  
28.  tetrapyrrole methylase family protein  
29.  Single-strand binding protein family  
30.  carboxyl-terminal protease  
31.  excinuclease ABC, B subunit  
32.  MutS domain protein  
33.  L-lactate permease  
34.  electron transfer flavoprotein, beta subunit  
35.  tldD protein truncated  
36.  TldD/PmbA family protein  
37.  excinuclease ABC, A subunit  
38.  cell cycle protein, FtsW/RodA/SpoVE family  
39.  Penicillin binding protein transpeptidase domain protein  
40.  excinuclease ABC, C subunit  
41.  UDP-N-acetylenolpyruvoylglucosamine reductase  
42.  ABC transporter, permease protein, FecCD family  
43.  iron compound ABC transporter, ATP-binding protein, putative  
44.  3-oxoacyl-(acyl-carrier-protein) synthase III  
45.  acetyl-CoA carboxylase, biotin carboxyl carrier protein  
46.  beta-hydroxyacyl-(acyl-carrier-protein) dehydratase FabZ  
47.  acetyl-CoA carboxylase, carboxyl transferase, beta subunit  
48.  acetyl-CoA carboxylase, carboxyl transferase, alpha subunit  
49.  ribosomal large subunit pseudouridine synthase B  
50.  probable flavoprotein, YhiN family  
51.  cytidylate kinase  
52.  4-hydroxy-3-methylbut-2-enyl diphosphate reductase  
53.  citrate lyase, alpha subunit  
54.  malate oxidoreductase (NAD) (malic enzyme)  
55.  formate acetyltransferase  
56.  pyruvate formate-lyase activating enzyme  
57.  LexA repressor  
58.  site-specific recombinase, phage integrase family  
59.  lysine-specific permease  
60.  undecaprenol kinase, putative  
61.  mannose-6-phosphate isomerase, class I  
62.  Mur ligase family protein  
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63.  CobB/CobQ family glutamine amidotransferase  
64.  stage V sporulation protein B  
65.  pseudouridylate synthase  
66.  amidohydrolase family protein  
67.  ATP-dependent DNA helicase PcrA, putative  
68.  uracil permease  
69.  drug resistance transporter, EmrB/QacA family  
70.  magnesium transporter  
71.  NADPH-dependent butanol dehydrogenase  
72.  oligopeptide transporter, OPT family  
73.  hypothetical protein  (CPR_1285) 
74.  SsrA-binding protein  
75.  phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent  
76.  RNA polymerase sigma-54 factor  
77.  primosome assembly protein PriA  
78.  conserved hypothetical protein  (CPR_1721) 
79.  L-asparaginase, type II  
80.  sensory box histidine kinase  
81.  transcriptional regulator, NrdR family  
82.  RNA polymerase sigma-G factor  
83.  cell division protein FtsZ  
84.  cell division protein FtsA  
85.  twitching motility protein PilT  
86.  peptidase, U32 family  
87.  conserved hypothetical protein  (CPR_1743) 
88.  RNA-metabolizing metallo-beta-lactamase family protein  
89.  segregation and condensation protein B  
90.  segregation and condensation protein A  
91.  tyrosine recombinase XerD  
92.  NAD(+)/NADH kinase  
93.  hemolysin A  
94.  geranyltranstransferase  
95.  translation elongation factor P  
96.  pilus biogenesis protein, putative  
97.  diaminopimelate epimerase  
98.  methyltransferase, putative  
99.  stage V sporulation protein E  
100.  phospho-N-acetylmuramoyl-pentapeptide-transferase  
101.  UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase  
102.  udp-n-acetylmuramoylalanyl-d-glutamate--2,6-diaminopimelate  
103.  stage V sporulation protein D, spoVD, FtsI/pbp family  
104.  teichoic acid biosynthesis protein A  
105.  stage V sporulation protein D, spoVD, FtsI/pbp family  
106.  MutS2 family protein  
107.  potassium uptake protein, TrkH family  
108.  ribosomal protein L20  
109.  translation initiation factor IF-3  
110.  aspartate-semialdehyde dehydrogenase  
111.  dihydrodipicolinate reductase  
112.  cob(I)alamin adenosyltransferase, putative  
113.  2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase, putative  
114.  membrane proteins-like protein lmo0908, putative  
115.  bacterial extracellular solute-binding proteins, family 5 superfamily  
116.  bacterial type II secretion system protein F  
117.  secretion system protein E  
118.  hypothetical protein  (CPR_2297) 
119.  ribosomal large subunit pseudouridine synthase f  
120.  2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase  
121.  phosphoglucosamine mutase  
122.  sensor protein yycg  
123.  two-component response regulator  
124.  4-alpha-glucanotransferase  
125.  transcriptional regulator, LacI family  
126.  conserved hypothetical protein  (CPR_2346) 
127.  thioredoxin reductase  
128.  phosphoenolpyruvate-protein phosphotransferase  
129.  ribosomal protein S4  
130.  ribonucleotide-diphosphate reductase subunit beta Bioinformation   open access 
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131.  sensor histidine kinase  
132.  DNA-binding response regulator  
133.  ribosomal protein S9  
134.  ribosomal protein L13  
135.  ABC transporter permease protein  
136.  ribosomal protein L17  
137.  DNA-directed RNA polymerase, alpha subunit  
138.  ribosomal protein S4  
139.  ribosomal protein S11  
140.  ribosomal protein S13p/S18e  
141.  preprotein translocase, SecY subunit  
142.  ribosomal protein L15  
143.  ATP-binding protein  
144.  hypothetical protein (CPR_0337) 
145.  DNA polymerase III, alpha subunit, interruption-C  
146.  cardiolipin synthetase  
147.  phosphopentomutase  
148.  quinolinate synthetase complex, A subunit  
149.  PTS system, IIB component  
150.  LacI family transcription regulator  
151.  PTS system, IIBC component  
152.  helicase/exonuclease  
153.  tRNA (guanine-N(7)-)-methyltransferase  
154.  ABC transporter domain protein  
155.  DNA-binding response regulator  
156.  glycosyltransferase, putative  
157.  beta-1,4-N-acetyl-mannosaminyltransferase, putative  
158.  polysaccharide transporter protein, putative  
159.  UTP-glucose-1-phosphate uridylyltransferase  
160.  UTP-glucose-1-phosphate uridylyltransferase  
161.  ABC transporter, permease protein  
162.  hypothetical protein  (CPR_0491) 
163.  NAD-dependent 4-hydroxybutyrate dehydrogenase 
164.  permease  
165.  nitrite/sulfite reductase-like protein  
166.  stage V sporulation protein D  
167.  riboflavin biosynthesis protein RibD  
168.  riboflavin synthase, alpha subunit  
169.  riboflavin biosynthesis protein RibA  
170.  phosphate permease  
171.  fructose specific permease  
172.  1-phosphofructokinase  
173.  diaminopimelate decarboxylase  
174.  amino acid ABC transporter, permease protein-like protein lin2352  
175.  cation efflux family protein  
176.  transporter-like protein lin1189  
177.  glycosyltransferase  
178.  polysaccharide biosynthesis protein, putative  
179.  DNA-binding response regulator  
180.  glutaminyl-tRNA synthetase  
181.  tyrosyl-tRNA synthetase  
182.  relA/spoT family protein   
183.  BirA bifunctional protein  
184.  degV family protein  
185.  rRNA methylase-like protein cspR  
186.  autolytic lysozyme, putative  
187.  sensory box histidine kinase  
188.  endonuclease III  
189.  serine O-acetyltransferase  
190.  amino acid (glutamine) ABC transporter, permease protein-like protein lin1851  
191.  amino acid ABC transporter ATP-binding protein  
192.  putative lipid kinase  
193.  phosphomethylpyrimidine kinase  
194.  transcriptional regulator, LacI family  
195.  d-galactose-binding periplasmic protein precursor  
196.  Galactoside transport ATP-binding protein mglA  
197.  beta-methylgalactoside transporter inner membrane component  
198.  fructose-1,6-bisphosphate aldolase, class II  Bioinformation   open access 
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199.  aminotransferase family protein  
200.  GTPase EngB  
201.  purine nucleoside phosphorylase  
202.  thiamine biosynthesis/tRNA modification protein ThiI  
203.  sodium/alanine symporter  
204.  cardiolipin synthase  
205.  glutamyl-tRNA reductase  
206.  oligoendopeptidase F  
207.  aminotransferase, class V  
208.  deoxyuridine 5'-triphosphate nucleotidohydrolase  
209.  sulfate permease, SulP family  
210.  nitrate ABC transporter ATP binding protein  
211.  uracil transporter  
212.  sucrose-6-phosphate hydrolase  
213.  sucrose operon repressor  
214.  spoVK domain protein  
215.  molybdopterin oxidoreductase  
216.  undecaprenyl diphosphate synthase, putative  
217.  ABC transporter (permease proteins)-like protein lmo1390  
218.  glycogen branching enzyme  
219.  DNA-binding response regulator  
220.  sensor histidine kinase  
221.  GTP pyrophosphokinase  
222.  protein-export membrane protein SecF  
223.  protein-export membrane protein SecD  
224.  holliday junction DNA helicase RuvB  
225.  holliday junction DNA helicase RuvA  
226.  conserved hypothetical protein  (CPR_1923) 
227.  hypoxanthine phosphoribosyltransferase  
228.  membrane carboxypeptidase mrcB  
229.  sodium/alanine symporter family protein  
230.  spermidine/putrescine ABC transporter, permease protein (potB)-like protein  
231.  spermidine/putrescine ABC transporter, permease protein (potC)-like protein  
232.  spermidine/putrescine-binding periplasmic protein precursor  
233.  aspartate--ammonia ligase  
234.  lrgB-like family protein  
235.  aminopeptidase  
236.  hypothetical protein  (CPR_1972) 
237.  hypothetical protein  (CPR_1973) 
238.  RNA polymerase sigma factor RpoD  
239.  DNA primase  
240.  pyruvate,phosphate dikinase  
241.  GTP-binding protein Era  
242.  hypothetical protein  (CPR_1998) 
243.  ribosomal protein L11 methyltransferase  
244.  heat-inducible transcription repressor HrcA  
245.  DNA polymerase III, delta subunit  
246.  ATP-dependent protease  
247.  deoxyribose-phosphate aldolase  
248.  manganese-dependent inorganic pyrophosphatase, putative  
249.  UDP-N-acetylglucosamine- -N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase  
250.  DNA topoisomerase, GyrA/ParC subunit family  
251.  ROK family protein  
252.  sugar transport system (permease) (binding protein dependent transporter)  
253.  FemAB family protein  
254.  glutamine-binding periplasmic protein of glutamine ABC transporter  
255.  vncR, response regulator  
256.  ABC transporter (ATP binding protein)-like protein lmo1063  
257.  ribosomal protein S5  
258.  ribosomal protein L18  
259.  ribosomal protein L6  
260.  ribosomal protein S8  
261.  ribosomal protein L5  
262.  ribosomal protein L14  
263.  50S ribosomal protein L16  
264.  30S ribosomal protein S3  
265.  ribosomal protein L22  
266.  ribosomal protein L3  Bioinformation   open access 
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267.  ribosomal protein S10  
268.  ribosomal protein S7  
269.  ribosomal protein S12  
270.  ribosomal protein L7/L12  
271.  50S ribosomal protein L10  
272.  ribosomal protein L1  
273.  ribosomal protein L11  
274.  transcription termination/antitermination factor NusG  
275.  thymidylate synthase, flavin-dependent  
276.  2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase  
277.  DNA repair protein RadA  
278.  transcriptional regulator, GntR family  
279.  thioredoxin-disulfide reductase  
280.  UDP-N-acetylmuramoylalanine--D-glutamate ligase  
281.  transcription elongation factor GreA  
282.  tRNA(Ile)-lysidine synthetase  
283.  MazG family protein  
284.  stage V sporulation protein B  
285.  thiamine biosynthesis protein ThiC  
286.  phosphoribosylaminoimidazole carboxylase, catalytic subunit  
287.  3-dehydroquinate synthase  
288.  chorismate synthase  
289.  3-dehydroquinate dehydratase, type II  
290.  hypothetical protein (CPR_0697) 
291.  probable permease, putative  
292.  Cytochrome C biogenesis protein transmembrane region family  
293.  ABC transporter, ATP-binding protein  
294.  cardiolipin synthetase  
295.  sodium:glactoside symporter family protein  
296.  antibiotic ABC transporter ATP binding protein SSO1934  
297.  acyl carrier protein phosphodiesterase  
298.  iron compound ABC transporter, permease protein  
299.  iron(III) dicitrate transport permease-like protein yusV  
300.  cymH protein  
301.  iron compound ABC transporter, permease protein  
302.  ferrichrome transport system, permease protein  
303.  Ferrichrome transport ATP-binding protein fhuC  
304.  ISCpe6, transposase orfA  
305.  NADH-dependent butanol dehydrogenase a  
306.  GntP family permease  
307.  uncharacterized conserved protein, YHAD family  
308.  MATE efflux family protein  
309.  thermophilic metalloprotease family protein  
310.  sucrose-6-phosphate hydrolase e1  
311.  PTS system, N-acetylglucosamine-specific IIBC component  
312.  cation efflux family protein  
313.  DNA-binding response regulator  
314.  pyridine nucleotide-disulphide oxidoreductase family protein  
315.  triple helix repeat-containing collagen  
316.  sensory box histidine kinase/response regulator  
317.  L-serine dehydratase, iron-sulfur-dependent, alpha subunit  
318.  oxidoreductase, 2-nitropropane dioxygenase family  
319.  HPr(Ser) kinase/phosphatase  
320.  methylglyoxal synthase  
321.  Predicted metal-dependent phosphoesterase (PHP family)  
322.  para-aminobenzoate synthase glutamine amidotransferase, component II  
323.  para-aminobenzoate synthase, component I  
324.  dihydropteroate synthase  
325.  dihydroneopterin aldolase/ 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase  
326.  thiazole biosynthesis protein ThiG  
327.  transporter, major facilitator family  
328.  methionine-R-sulfoxide reductase  
329.  transcriptional regulator, LacI family  
330.  teichoic acid linkage unit synthesis protein-like protein lin2663  
331.  ferripyochelin binding protein  
332.  HD superfamily hydrolase, YMDA  
333.  recA protein  
334.  CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase  Bioinformation   open access 
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335.  DNA translocase FtsK  
336.  aspartokinase  
337.  riboflavin biosynthesis protein RibF  
338.  DHH subfamily 1 protein  
339.  DNA polymerase III, alpha subunit, Gram-positive type  
340.  4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase  
341.  1-deoxy-D-xylulose 5-phosphate reductoisomerase  
342.  phosphatidate cytidylyltransferase  
343.  ribosome recycling factor  
344.  uridylate kinase  
345.  translation elongation factor Ts  
346.  ribosomal protein S2  
347.  GTP-sensing transcriptional pleiotropic repressor CodY  
348.  DNA protecting protein DprA  
349.  ribonuclease HII  
350.  ribosomal protein L19  
351.  radical SAM domain-containing protein  
352.  fatty acid/phospholipid synthesis protein PlsX 
353.  acetate kinase  
354.  phosphate acetyltransferase  
355.  pantetheine-phosphate adenylyltransferase  
356.  ATP-dependent DNA helicase RecG  
357.  DAK2 domain protein  
358.  GTPase YjeQ  
359.  protein phosphatase 2C family protein  
360.  polypeptide deformylase  
361.  pseudouridylate synthase family protein, yabo  
362.  nicotinate nucleotide adenylyltransferase  
363.  ribosomal protein L27  
364.  ribonuclease, Rne/Rng family  
365.  cell cycle protein, FtsW/RodA/SpoVE family  
366.  septum site-determining protein MinD  
367.  Penicillin-binding Protein dimerisation domain family  
368.  rod shape-determining protein MreB  
369.  DNA repair protein, RadC family  
370.  hypothetical protein  (CPR_2114) 
371.  aminoacyl-histidine dipeptidase  
372.  hypothetical protein  (CPR_2119) 
373.  PTS system, glucose-specific IIBC component  
374.  ABC transporter, substrate-binding protein  
375.  conserved hypothetical protein  (CPR_2132) 
376.  glycoprotease family protein  
377.  preprotein translocase, SecA subunit  
378.  RecD/TraA family helicase  
379.  mbl protein  
380.  UDP-N-acetylglucosamine 1-carboxyvinyltransferase  
381.  UDP-N-acetylglucosamine 2-epimerase  
382.  uracil phosphoribosyltransferase  
383.  ribose 5-phosphate isomerase b  
384.  Sua5/YciO/YrdC/YwlC family protein  
385.  modification methylase, HemK family  
386.  thymidine kinase  
387.  transcription termination factor Rho  
388.  4-diphosphocytidyl-2C-methyl-D-erythritol kinase  
389.  sensor histidine kinase HpkA  
390.  DNA-binding response regulator  
391.  aminoacyl-histidine dipeptidase  
392.  non-canonical purine NTP pyrophosphatase, rdgB/HAM1 family  
393.  ribonuclease PH  
394.  glucose-6-phosphate isomerase  
395.  oligopeptide ABC transporter, ATPase component  
396.  oligopeptide ABC transporter, ATPase component  
397.  oligopeptide ABC transporter, permease component  
398.  oligopeptide ABC transporter, permease component  
399.  transcription-repair coupling factor  
400.  PDZ domain protein  
401.  sensor histidine kinase  
402.  DNA-binding response regulator  Bioinformation   open access 
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403.  UDP-N-acetylglucosamine pyrophosphorylase  
404.  UDP-N-acetylmuramate--alanine ligase  
405.  Transcriptional regulator  
406.  metallopeptidase, family M24  
407.  primase-like protein  
408.  bifunctional acetaldehyde-CoA/alcohol dehydrogenase  
409.  catabolite control protein A, putative  
410.  glycerol uptake operon antiterminator  
411.  glutamate racemase  
412.  glutamine synthetase, putative  
413.  Transcriptional regulator  
414.  metallo-beta-lactamase family protein  
415.  UDP-N-acetylglucosamine 1-carboxyvinyltransferase  
416.  YhiN family flavoprotein  
417.  L-serine dehydratase, iron-sulfur-dependent, alpha subunit  
418.  class II aldolase, tagatose bisphosphate family  
419.  replicative DNA helicase  
420.  ATP-dependent protease  
421.  ribosomal protein L9  
422.  DHH family protein  
423.  stage 0 sporulation protein J  
424.  sporulation initiation inhibitor protein soj  
425.  methyltransferase GidB  
426.  membrane protein OxaA  
 